What is the appropriate volume to re-irradiate in a recurrent GBM?  

If a patient has increasing FLAIR and T1 enhancing activity, should both be included in the treatment volume? What factors to you consider in making your decision (such as PFS since prior CRT, KPS, etc)?

Answer from: Radiation Oncologist at Academic Institution